1. Home
  2. INUV vs RGNT Comparison

INUV vs RGNT Comparison

Compare INUV & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inuvo Inc.

INUV

Inuvo Inc.

HOLD

Current Price

$1.26

Market Cap

24.2M

ML Signal

HOLD

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$3.88

Market Cap

24.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INUV
RGNT
Founded
N/A
2004
Country
United States
Israel
Employees
N/A
8
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.2M
24.6M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
INUV
RGNT
Price
$1.26
$3.88
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
142.2K
13.7M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
50.00
N/A
EPS
0.13
N/A
Revenue
$86,209,305.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.89
N/A
P/E Ratio
$9.54
N/A
Revenue Growth
2.88
N/A
52 Week Low
$1.21
$1.23
52 Week High
$6.27
$15.50

Technical Indicators

Market Signals
Indicator
INUV
RGNT
Relative Strength Index (RSI) 31.45 53.12
Support Level N/A $1.95
Resistance Level $2.01 $7.80
Average True Range (ATR) 0.10 2.17
MACD -0.00 0.05
Stochastic Oscillator 16.13 18.79

Price Performance

Historical Comparison
INUV
RGNT

About INUV Inuvo Inc.

Inuvo Inc is an advertising technology and services company that has developed and commercialized large language generative artificial intelligence (AI) for modeling media audiences. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: